University of California, San Diego other research news

Most gene therapies are delivered by vectors derived from Moloney murine leukemia virus, but delivery efficiency has been low. As published in the Proceedings of the National Academy of Sciences, scientists may be able to improve the efficiency of infection with engineered viruses that are hybrids.

Cells that are infected naturally with a retrovirus and with a rhabdovirus called vesicular stomatitis virus (VSV) will produce viral offspring that consist of the genome of one virus coated with the envelope protein of the other. ...